addiction

Retail cannabis sales are associated with decreases in the use of alcohol, cigarettes and pain medications by young adults, according to data published in the Journal of Adolescent Health, reported NORML. Highlights Of The Study Researchers with the University of Washington assessed trends in...

This article was originally published on Cannabis.net and appears here with permission. Should we demonize drug use for the youth in order to deter them from consuming them? One Reddit user believes so as he wrote in this post entitled, “Demonizing drugs among young adults and adults (even...

This article was originally published on Askgrowers and appears here with permission. Marijuana, or popularly known as cannabis, has always been a subject of debate amongst many. While some individuals believe that marijuana is a harmless plant, others argue that it is addictive and can act as...

The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis by partnering with neuroscience company Delix Therapeutics to study a non-hallucinogenic version of the psychedelic drug ibogaine.   Collaboration with the National Institute...

Novamind Inc. (OTCQB: NVMDF), a mental health company specializing in psychedelic medicine, has announced the launch of a new clinic located in downtown Salt Lake City specializing in integrative behavioral health and services for adults with substance use disorders.  The company notes that in...

This article by Carlos Alberto Barzani, Psychologist, was originally published on El Planteo. The matter of prevention is always a challenging subject, as it aims to improve health conditions and to anticipate harm, in order to avoid it. However, the human psyche is very complex; and sometimes it...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Two doses of psilocybin over a period of eight weeks significantly reduced alcohol use and cravings for alcoholics. That’s according to early results of a New York...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Access to ibogaine treatment could help slow the river of opioid addiction around the world. Here’s how it works. Ibogaine treatment facilities are popping up...

In an exclusive to Benzinga, Mind Medicine (MindMed) Inc (OTC: MMEDF), a leading medicine biotech company in psychedelics, on Tuesday revealed the introduction of a division known as Albert, to help research and develop an integrated platform for delivering psychedelic medicines, experiential...

This article was originally published on Microdose Psychedelic Insights, and appears here with permission. Recent figures estimate that the abuse of tobacco, alcohol, and drugs within the United States totals to over $1 trillion dollars a year in costs—and counting.1 Between the...

Among the biggest challenges faced by the psychedelics industry is the stigma that surrounds it. "The anti-drug marketing of the past decades was highly effective, and so now when psychedelics are mentioned, visions of tie-dye come to mind," Timothy Ko told Benzinga.  The times...

Biotech traders may want to keep an eye on Collegium Pharmaceuticals Inc (NASDAQ: COLL) on Thursday morning, as the stock may see increased activity due to an expert networking call between investors and an expert discussing the company's drug Xtampza ER. On April 27, the FDA approved Collegium's...

The Wall Street Journal recently reported President Obama’s administration will loosen its strict controls on a medication called buprenorphine, which is used to treat addiction to heroin and other opioid-based drugs. The Department of Health and Human Services up until now only allowed...